Literature DB >> 18653288

Multiple aortic aneurysms complicated by a rupture in the systemic lupus erythematosus: a case report.

Junichiro Sato1, Tomohiro Kawakami, Kimimasa Nakabayashi, Kazuhito Fukuoka, Kazuhiko Hirano, Yuichi Terado, Kenichi Yokoyama, Takako Ohtsuka, Yasuo Ohkura, Yasunori Fujioka, Atsushi Kurata.   

Abstract

We report the case of a 61-year-old female who suffered from systemic lupus erythematosus (SLE) and died of a ruptured abdominal aortic aneurysm (AA). She was diagnosed to have SLE at 39 years of age, and was administrated steroids and prostaglandin E(2). From 52 years of age, AA, peripheral arterial occlusion, and multiple organ infarctions appeared repeatedly. At 59 years of age, she was found to be affected by antiphospholipid antibody syndrome (APS). In the following year, expansion of an abdominal AA was identified, but she was given only conservative treatment. In the next year, sudden epigastralgia and dyspnea occurred, and she died. An autopsy revealed multiple AAs up to 11 cm in diameter, one of which showed ruptures, forming a retroperitoneal hematoma. Marked atherosclerosis of the aorta was noted, and she also had aortic dissection accompanied by cystic medial necrosis (CMN). An old myocardial infarction and brain infarction were also confirmed. Although SLE with APS is common, a complication of the disease by CMN, multiple AAs, or ruptured AA has been described in several cases to date. Regarding the etiology of this complicated presentation, we presume synergistic involvement of various factors, such as atherosclerosis and CMN associated with SLE, thrombosis due to APS, and prolonged steroid therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18653288     DOI: 10.1016/j.prp.2008.05.009

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  8 in total

Review 1.  Aortic aneurysm and dissection in systemic lupus erythematosus.

Authors:  Shi-Min Yuan
Journal:  Z Rheumatol       Date:  2019-04       Impact factor: 1.372

2.  Surgical treatment of acute aortic dissection in a patient with SLE and prior antiphospholipid syndrome on therapy for over 30 years: a case report.

Authors:  Taira Yamamoto; Daisuke Endo; Akie Shimada; Satoshi Matsushita; Tohru Asai; Atsushi Amano
Journal:  BMC Cardiovasc Disord       Date:  2022-05-13       Impact factor: 2.174

3.  Premature aortic atherosclerosis in systemic lupus erythematosus: a controlled transesophageal echocardiographic study.

Authors:  Carlos A Roldan; Joseph Joson; Janeen Sharrar; Clifford R Qualls; Wilmer L Sibbitt
Journal:  J Rheumatol       Date:  2009-12-01       Impact factor: 4.666

4.  Relation of antiphospholipid antibodies to postmortem brain infarcts in older people.

Authors:  Zoe Arvanitakis; Robin L Brey; Jacob H Rand; Julie A Schneider; Ana W Capuano; Lei Yu; Sue E Leurgans; David A Bennett; Steven R Levine
Journal:  Circulation       Date:  2014-10-09       Impact factor: 29.690

5.  Aortic Atherosclerosis in Systemic Lupus Erythematosus.

Authors:  Paola C Roldan; Michelle Ratliff; Richard Snider; Leonardo Macias; Rodrigo Rodriguez; Wilmer Sibbitt; Carlos A Roldan
Journal:  Rheumatology (Sunnyvale)       Date:  2014

6.  Rare Association of Antiphospholipid Antibody Syndrome, Systemic Lupus Erythematosus and Aortic Dissection: A Striking Presentation with Multi-Organ Failure?

Authors:  Firdevs Ulutaş; Veli Çobankara; Aslı Bozdemir; Uğur Karasu
Journal:  Eur J Case Rep Intern Med       Date:  2020-08-27

7.  Arterial Dissection in Antiphospholipid Syndrome Patients: Two Case Reports and a Literature Review.

Authors:  Kadhim Al-Banaa; Alfarooq Alshaikhli; Asal Al-Hareeri; Mohammed Abdelhalim; Alsadiq Al-Hillan; Tejas Joshi
Journal:  Eur J Case Rep Intern Med       Date:  2021-05-24

8.  Primary Antiphospholipid Antibody Syndrome Complicated with Cerebellar Hemorrhage and Aortic Dissection: A Case Report.

Authors:  Yoshio Tatsuoka; Yui Mano; Shuichi Ishikawa; Shigeru Shinozaki
Journal:  Am J Case Rep       Date:  2019-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.